News
Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support ...
Thermo Fisher Scientific Inc. (Waltham, Mass.) announced an expansion of their strategic partnership with Sanofi S.A. (Paris, France) to enable additional ...
11h
Zacks Investment Research on MSNSanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track TagSanofi SNY has announced that the FDA has granted a fast-track designation to its one-time intravitreal gene therapy, SAR446597, for the treatment of geographic atrophy (GA) due to age-related macular ...
In a move to bolster its drug manufacturing capabilities in the United States, Thermo Fisher has purchased a sterile ...
(Reuters) -Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce ...
Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...
Explore more
Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product manufacturing.
Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product ...
Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...
Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the most notable here.
Second, we built a culture that values impact over broad activity. As AI increasingly handles routine tasks that once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results